XJPX
4968
Market cap144mUSD
Dec 05, Last price
1,134.00JPY
1D
-0.09%
1Q
-1.31%
Jan 2017
-39.29%
Name
Arakawa Chemical Industries Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Arakawa Chemical Industries, Ltd. manufactures and sells chemicals for functional coating agents, paper manufacturing, resins for printing inks and adhesives, materials for electronic materials, etc. in Asia, China, Europe, and the United States. The company offers various paper chemicals for the manufacture of books, newspapers, tissues, and other types of papers, including water-repellents, sizing agents, paper surface improving agents, and paper strengthening agents for the strength of paper and corrugated cardboard. It also provides coating chemicals and adhesive materials, such as printing inks for offset printing; book (magazine)-gravures and food-package-gravures; tackifiers for adhesive agents or tapes; release agents for release paper; polymerization emulsifiers for producing synthetic rubber; ester gums that enhance chewing sensations; and resins as a raw material of paint or film coating, as well as hydrogenated petroleum resins and colorless rosin derivatives under the ARKON and PINECRYSTAL names. In addition, the company offers electronic materials, including rosin-modified phenolic, polyurethane resins, polyurethane, alkyd, polyester, modified epoxy, and hydrogenated hydrocarbon resins; rosin ester products; cleaning systems and peripheral equipment. Further, it provides photo-curing polymers, organic-inorganic hybrid resins, and hybrid polyimide films. The company was formerly known as Arakawa Forest Chemical Industries, Ltd. and changed its name to Arakawa Chemical Industries, Ltd. in April 1977. Arakawa Chemical Industries, Ltd. was founded in 1876 and is headquartered in Osaka, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||